Cigna’s $30.35 EPS Floor: Can Evernorth Offset Pharmacy Margin Pressure?

The Cigna Group reported strong financial and operational results in the first quarter of 2026, highlighted by total revenues of $68.5 billion and adjusted earnings per share of $7.79, representing a 16% increase year-over-year. The company raised its full-year adjusted earnings per share guidance to at least $30.35, reflecting confidence in sustained growth driven by disciplined execution, strategic portfolio management, and continued investments in innovation. The company operates two primary segments: Evernorth Health Services and Cigna Healthcare, both contributing positively to overall performance. Evernorth’s revenue grew 9% to $58.4 billion, with pretax adjusted earnings up 2% to $1.5 billion, slightly ahead of expectations. Specialty and Care Services, Evernorth’s fastest-growing businesses, delivered pretax adjusted earnings growth of 20%, benefiting from increasing demand for specialty drugs and rising adoption of biosimilars and specialty generics.